Brazil rejects Dr Reddy’s, Cipla GLP-1 generics on technical grounds(Soban News)

Brazil’s regulator Anvisa rejects DRL and Cipla’s generic GLP-1 drug filings, citing unmet technical requirements on efficacy, safety and quality

​Brazil’s regulator Anvisa rejects DRL and Cipla’s generic GLP-1 drug filings, citing unmet technical requirements on efficacy, safety and quality by Soban News (international And National News)